International Clinical Trial: A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07444385) titled 'A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Addpharma Inc.

Condition: Benign Prostatic Hyperplasia

Intervention: Drug: AD-116, AD-1161

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: February 26, 2026

Target Sample Size: 44

Countries of Recruitment: South Korea

To know more, visit https://clinicaltrials.gov/study/NCT07444385

P...